Buy, hold or sell these 3 ASX 200 healthcare shares: Experts

These experts reveal their calls on CSL, Resmed and Sonic Healthcare shares today.

| More on:
Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

ASX 200 healthcare shares are in the red with the rest of the market on Friday.

The S&P/ASX 200 Health Care Index (ASX: XHJ) is down 1.53% while the S&P/ASX 200 Index (ASX: XJO) is down 0.53%. This follows a subdued session on Wall Street overnight after yesterday's exuberance.

Here, we canvas expert opinions on three of the largest and most popular ASX 200 healthcare stocks on the market today.

Expert verdicts on 3 top ASX 200 healthcare shares

CSL Ltd  (ASX: CSL)

CSL is the biggest ASX 200 healthcare share by far, with a market capitalisation of $138.67 billion.

The CSL share price is $281.38, down 1.94% at the time of writing and down 7.5% over the past 12 months.

Jed Richards of Shaw and Partners has a buy rating on CSL shares.

He told The Bull this week:

This well managed blood products company offers compelling long-term tailwinds.

CSL is steadily growing its dividend stream. The company usually under-promises and over-delivers when it comes to profit. The stock has underperformed on the back of a slower recovery in margins.

Also behind a weaker share price was a phase 3 study which found its CSL112 drug was unable meet its primary efficacy endpoint of reducing the risk of major adverse cardiovascular events in patients at 90 days following a first heart attack.

The recent share price presents an attractive entry level for investors.

Sonic Healthcare Ltd (ASX: SHL)

Sonic Healthcare is the fifth largest ASX 200 healthcare stock with a market cap of $12.99 billion.

The Sonic Healthcare share price is $26.99, down 0.19% now and down 24.4% over the past 12 months.

Toby Grimm of Baker Young has a hold rating on Sonic Healthcare shares.

Grimm says:

Australia's largest pathology testing firm remains out of favour as it loses prior windfall COVID-19 revenues amid an elevated operating cost environment.

However, we see fiscal year 2024 as the low point for earnings. Moving forward, we expect growth across its global core business as a prime reason to consider holding the stock.

Resmed CDI (ASX: RMD)

Resmed is the third biggest ASX 200 healthcare share with a market cap of $21.12 billion.

The Resmed share price is $32.99, down 0.33% now and down 3.74% over the past 12 months.

Grimm has a sell rating on Resmed shares.

He explains:

The sleep apnoea device maker delivered impressive third quarter results in fiscal year 2024. RMD's share price has surged relative to the market and its peers.

While long term growth is likely, the impact from new weight loss drugs remains uncertain, so we suggest investors consider reducing exposure and cashing in some gains.

Motley Fool contributor Bronwyn Allen has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and ResMed. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended CSL and Sonic Healthcare. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

woman sitting at desk holding hand up in stop motion
Healthcare Shares

Guess which high-flying ASX All Ords stock was just halted ahead of a key FDA decision

The ASX All Ords stock is awaiting an important announcement from the US FDA.

Read more »

Scientist looking at a laptop thinking about the share price performance.
Healthcare Shares

Is the slashed Sonic Healthcare share price a 'buying opportunity'?

Is this stock a healthy opportunity?

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Healthcare Shares

ASX healthcare stock surges 11% on 'incredibly valuable' FDA news

Some big news is getting investors excited on Tuesday. What's happening?

Read more »

A man thinks very carefully about his money and investments.
Healthcare Shares

How much could $10,000 invested in CSL shares be worth next year?

Do analysts think it would be worth sinking money into this top stock?

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Healthcare Shares

This ASX All Ords stock is rocketing 20% after accepting a takeover offer

These two diagnostics companies are planning to merge their operations.

Read more »

A man sleeps in a bed with white sheets while holding a teddy bear and a smile on his face.
Healthcare Shares

Buy the ASX 200 healthcare stock with 'decades of growth ahead'

This healthcare giant is well positioned for growth, experts say.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Telix Pharmaceuticals share price sinks on unexpected Nasdaq news

ASX 200 investors are bidding down the Telix Pharmaceuticals share price today. But why?

Read more »

Health workers shake hands and congratulate each other on good news.
Healthcare Shares

This ASX 200 healthcare stock is up 48% in a year, but one director is still buying!

A director of this ASX 200 healthcare company has just lifted his personal stake by 50%.

Read more »